OVERLAND PARK, Kan.--Vince & Associates Clinical Research, a premier provider of early phase clinical research services to the global biopharmaceutical industry, announced today the expansion of its capabilities in the gastrointestinal (GI) therapeutic area with the addition of a dedicated Endoscopy Suite at its Clinical Pharmacology Unit.
"Vince and Associates Clinical Research has successfully conducted a number of studies evaluating potential therapies in patients with gastrointestinal disorders. To supplement ongoing research, VACR has established an Endoscopy Suite to offer on-site access to a wide range of endoscopic procedures," said Dr. Brad Vince, CEO and medical director of Vince & Associates. "This investment reaffirms our dedication to providing research expertise in response to increasing demand for conducting clinical research in patient populations during early development, which often requires more specialized techniques."
The suite is equipped with advanced and minimally invasive video endoscopy technology from Olympus EndoTherapy. Procedures can be viewed remotely on a large screen and documented by video or still photography. The suite includes two sources of suction as well as resuscitation and medication stations to address patient safety and equipment is maintained at the purpose built disinfection station.
In addition to creating the Endoscopy Suite, VACR has reached out to Summit Gastroenterology for their medical expertise to complement the new research capabilities. Their Board Certified Gastroenterologists have been asked to join the Vince & Associates Clinical Research team as investigators, bringing significant clinical expertise as GI specialists.
Dr. Brad Vince stated, "The endoscopy suite and additional medical expertise significantly broaden the clinical research capabilities we are able to offer our clients. This investment will be key for clients seeking to obtain safety and efficacy data in patients and healthy normal volunteers during the early development phase to more quickly reach sound drug development decisions."
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for more than a decade. Proud to be recognized in the industry as a "Center of Research Excellence", Vince & Associates has become a premier clinical research site by utilizing The Physician Research Model® of operation where study teams are led by highly experienced principal investigators intimately involved in all aspects of the clinical trial process.
Vince & Associates operates a state-of-the-art, multimillion-dollar, 90-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials, from the safety and security of the controlled access unit to the added features of a movie theater and game rooms.
About Altasciences
Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA) and Algorithme Pharma (Quebec, Canada). Both organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.
More Information
Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website athttp://www.vinceandassociates.com.
Contacts
Vince & Associates Clinical Research
Bruce Copeland, 913-696-1601
[email protected]